(Q61921394)

English

Investigating the Pharmacokinetics and Pharmacodynamics of Recombinant Human Insulin Administered by Dry Powder Inhaler

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

Evaluation of the Pharmacokinetics and Pharmacodynamics of Spray-Dried Recombinant Human Insulin Powder for Inhalation Administered Via a Dry Powder Inhalation Device Relative to SC Recombinant Human Insulin in Healthy Male Volunteers (English)

0 references

medical condition

diabetes

0 references

country

United States of America

0 references

main subject

pharmacokinetics

0 references

start time

February 2007

0 references

number of participants

14

0 references

clinical trial phase

phase I clinical trial

0 references

research subject recruitment status

unknown

0 references

minimum age

18 year

0 references

maximum age

45 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT00426920

0 references

(Q61921394)

Investigating the Pharmacokinetics and Pharmacodynamics of Recombinant Human Insulin Administered by Dry Powder Inhaler

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)